Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dongil Pharmtec is a South Korean pharmaceutical company established in 1984 that specializes in the development and manufacturing of a wide range of medicinal products, including prescription drugs, over-the-counter (OTC) medications, and medical devices. The company is particularly recognized for its expertise in topical formulations such as ointments, creams, and patches, as well as external liquid medicines. Dongil Pharmtec operates a GMP-certified manufacturing facility in Ansan, Gyeonggi-do, where it produces various treatments for dermatological conditions, pain management, and general health. In addition to its own branded products, the company provides contract manufacturing services and engages in the distribution of health supplements and quasi-drugs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dong Il Pharmtec.